NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 11894.25 -1.20 -0.01%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

BioAlliance Pharma (EPA: BIO)

 
BIO Technical Analysis
2
As on 31st Jul 2014 BIO Share Price closed @ 7.40 and we RECOMMEND Buy for LONG-TERM with Stoploss of 6.51 & Strong Sell for SHORT-TERM with Stoploss of 7.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BIO Share Price

Open 7.62 Change Price %
High 7.63 1 Day -0.20 -2.63
Low 7.36 1 Week 0.00 0.00
Close 7.40 1 Month 0.00 0.00
Volume 135061 1 Year 0.00 0.00
52 Week High 208.85 | 52 Week Low 66.52
 
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
GSZ 17.56 3.97%
BRS 12.00 0.00%
VK 4.72 0.43%
ALALO 0.04 0.00%
CS 26.31 1.47%
TEC 67.40 0.40%
ACA 14.98 0.00%
ALAUP 0.20 -13.04%
 
EPA France Top Gainers Stocks
MLFCI 0.31 34.78%
AVT 0.19 26.67%
AVT 0.19 26.67%
AVT 0.19 26.67%
AVT 0.19 26.67%
ALFRE 1.81 25.69%
CFI 2.01 20.36%
CFI 2.01 20.36%
CFI 2.01 20.36%
CFI 2.01 20.36%
 
EPA France Top Losers Stocks
MLROU 6.37 -34.19%
MLLEA 0.61 -23.75%
ALAUP 0.20 -13.04%
OXI 0.08 -11.11%
OXI 0.08 -11.11%
MLFXO 3.79 -9.98%
TONN 1.20 -9.77%
ALCLS 26.88 -9.22%
RUSAL 10.00 -9.09%
ALEUP 0.20 -9.09%
 
 
BIO
Daily Charts
BIO
Intraday Charts
Whats New @
Bazaartrend
BIO
Free Analysis
 
BIO Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE7.65
RESISTANCE7.55
SUPPORT7.25
SUPPORT7.15
SUPPORT0.00
SUPPORT0.00
 
BIO Target for Month November
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
BIO Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
BIO Target for Year 2019
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
BIO Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.bioalliancepharma.com
 
BIO Address
BIO
49 boulevard du G
Paris, 75015
France
Phone: 33 1 45 58 76 00
Fax: 33 1 45 58 08 81
 
BIO Latest News
 
Your Comments and Response on BioAlliance Pharma
 
BIO Business Profile
BioAlliance Pharma SA designs, develops, and markets drugs for the treatment of cancer primarily in France. Its specialty product portfolio includes Loramyc/Oravig, a mucoadhesive buccal tablet for the treatment of oropharyngeal candidiasis in patients with head and neck cancer or AIDS; Sitavig, a mucoadhesive buccal tablet to treat recurrent herpes labialis in immunocompetent patients; and Fluriad, an H1N1 vaccine that is in preclinical trials. The company’s ophan oncology product portfolio comprises Livatag, which is in phase III clinical trial for the treatment of hepatocellular carcinoma; Validive, a mucoadhesive buccal tablet that is in Phase II clinical trial for the prevention of chemo/radiation therapy-induced oral mucositis in patients with head and neck cancer; and AMEP/Synfoldin, a preclinical trial product for metastatic melanoma. BioAlliance Pharma SA was founded in 1997 and is based in Paris, France.
 
2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service